COLL · Company research
Collegium Pharmaceutical, Inc. Common Stock (COLL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 21.93 | $734,912,127.12 | 605445127.12 | 18.258064516129032 | — | — | — | 2.3561748045744111 | 10.3761577805074338 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.